Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to equity ratio is N/A as of Tuesday, October 6, 2026.
DEBT TO EQUITY RATIO
N/A
Market Cap
$141.70M
Debt to Equity Ratio
0.39
TTM Avg
2.42
3Y Avg
2.91
5Y Avg
2.20
Market Cap
$136.86M
Debt to Equity Ratio
0.67
TTM Avg
1.14
3Y Avg
1.25
5Y Avg
1.10
Market Cap
$144.07M
Debt to Equity Ratio
0.00
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
50.25
Market Cap
$135.97M
Debt to Equity Ratio
0.18
TTM Avg
0.22
3Y Avg
0.21
5Y Avg
0.14
Market Cap
$145.12M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.13
Market Cap
$146.84M
Debt to Equity Ratio
0.02
TTM Avg
0.06
3Y Avg
0.05
5Y Avg
0.05
Market Cap
$131.16M
Debt to Equity Ratio
1.69
TTM Avg
0.90
3Y Avg
0.77
5Y Avg
0.69
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $140.14M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $141.70M | 0.39 | 2.42 | 2.91 | 2.20 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $136.86M | 0.67 | 1.14 | 1.25 | 1.10 |
| Alpha Cognition Inc (ACOG)vs › | $144.07M | 0.00 | 0.01 | 0.01 | 50.25 |
| KORU Medical Systems, Inc. (KRMD)vs › | $135.97M | 0.18 | 0.22 | 0.21 | 0.14 |
| LifeMD, Inc. (LFMD)vs › | $135.66M | 0.76 | 0.27 | 2.83 | 1.63 |
| Korsana Biosciences, Inc. (KRSA)vs › | $145.12M | 0.00 | 0.00 | 0.00 | 0.13 |
| Immuneering Corporation (IMRX)vs › | $146.84M | 0.02 | 0.06 | 0.05 | 0.05 |
| Health Catalyst, Inc. (HCAT)vs › | $131.16M | 1.69 | 0.90 | 0.77 | 0.69 |
| Codexis, Inc. (CDXS)vs › | $150.05M | 2.20 | 1.17 | 0.71 | 0.54 |
Debt/Equity
N/A
Current Ratio
N/A
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
